Loading organizations...
Loading organizations...
Novel drug delivery for pain-free treatment of skin conditions.
Veradermics has raised $225.0M across 2 funding rounds.
Veradermics has raised $225.0M in total across 2 funding rounds.
Veradermics has raised $225.0M in total across 2 funding rounds.
Veradermics's investors include Katarina Pance, abrdn, Infinitium, Invus, LifeSci Venture Partners, Longitude Capital, Marshall Wace, Surveyor Capital, Suvretta Capital Management, Viking Global Investors, Amanda Birdsey-Benson, Vlad Coric.
Veradermics has raised $225.0M across 2 funding rounds. Most recently, it raised $150.0M Series C in October 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 16, 2025 | $150.0M Series C | Katarina Pance | abrdn, Infinitium, Invus, LifeSci Venture Partners, Longitude Capital, Marshall Wace, Surveyor Capital, Suvretta Capital Management, Viking Global Investors |
| Dec 11, 2024 | $75.0M Series B | Amanda Birdsey-Benson | Vlad Coric, Connecticut Innovations, J.W. Childs Associates, Patrick Enright, Osage University Partners, PhiFund Ventures, Surveyor Capital |